Study #2024-1886
Precision-MRD: Prospective observational study of biomarker-directed systemic therapy for colorectal cancer patients with minimal residual disease
MD Anderson Study Status
Enrolling
Treatment Agent
Description
The goal of this clinical research study is to learn about the effects of biomarkertargeted therapy on ctDNA in patrticipants with CRC and MRD. This is an observational study. Participants will be monitored while receiving biomarker-directed therapy that is determined by your treating oncologist (cancer doctor) per standard of care, independent of this study.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Colorectal Cancer
Study phase:
Physician name:
Saurav Haldar
Department:
Gastrointestinal Medical Oncology
For general questions about clinical trials:
1-844-931-2586
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.